AlphaMed Press has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.
William C. Weldon, chairman and chief executive officer of Johnson & Johnson, chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard™, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals. Today, nearly one million and a quarter employees and family members are benefiting from the vision and leadership of employers who have chosen to become Gold Standard accredited.
“The leadership and commitment to employee health of Gold Standard organizations is exemplary,” said Weldon. “AlphaMed Press is a premier publisher of internationally recognized scientific journals such as STEM CELLS and THE ONCOLOGIST and we hope that they will serve as a model for other employers, large and small, for-profit and not-for-profit, to foster a workplace culture of health and wellness.”
The CEO Cancer Gold Standard™ calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use; encouraging physical activity; promoting healthy diet and nutrition; detecting cancer at its earliest stages; and providing access to quality care, including participation in clinical trials.
“Medicine teaches us that a team approach is best to prevent and treat cancer,” said Ann Murphy, PhD, President of AlphaMed Press. “Receiving the CEO Cancer Gold Standard™ reflects AlphaMed Press’s commitment to being an active member of this team and we encourage other companies to proactively invest in their employees’ future well being by embracing the Gold Standard.”
Other organizations joining AlphaMed Press in championing this workplace-based effort to eliminate cancer as a public health threat include: Aetna, Aldagen, Inc., the American Cancer Society’s National Home Office and Mid-South Division, the American Legacy Foundation, the American Society of Clincial Oncology, Aptuit, AstraZeneca, C-Change, Cigna, Dana-Farber Cancer Institute, Duke Medicine, Edelman, Enzon Pharmaceuticals, Fox Chase Cancer Center, GlaxoSmithKline, Hawai'i Pacific Health, Hogan & Hartson, Independence Blue Cross, Jenner & Block, Johnson & Johnson, the Lance Armstrong Foundation, LiDestri Foods, M. D. Anderson Cancer Center, MDU Resources, Meridian Health, Millennium: The Takeda Oncology Company, Minot State University, H. Lee Moffitt Cancer Center and Research Institute, The National Cancer Institute, Nevada Cancer Institute, Novartis, The Oncology Nursing Society, OSI Pharmaceuticals, Pfizer, PhRMA, PPD, Pride, Inc., Quest Diagnostics, Quintiles Transnational, sanofi-aventis, SAS Institute, St. Barnabas Health Care System, State Farm, Susan G. Komen for the Cure, The University of North Dakota, US Oncology, Valeant Pharmaceuticals, Vanderbilt-Ingram Cancer Center, Virtua Health, WCA Hospital, Wistar Institute and XCelience, LLC.
About AlphaMed Press
Established in 1983, AlphaMed Press with offices in Durham, NC and Belfast, United Kingdom publishes two internationally renowned peer-reviewed journals: STEM CELLS®, now in its 28th year, is the world's first journal devoted to this fast paced field of research. The Oncologist® (www.TheOncologist.com), also a monthly peer-reviewed publication, is in its 15th year and is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. Both journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. AlphaMed Press publishes the Stem Cells Portal online (www.StemCellsPortal.com) and The Oncologist’s Community Multi-Media Portal (http://theoncologistcommunity.com), as well as freestanding monographs and books, and is renowned for its excellence and speed in the publication of the peer-reviewed proceedings of major international symposia. For more information on AlphaMed Press, please visit www.alphamedpress.org.